Survey of patients' views of domiciliary nebuliser treatment for chronic lung disease

Respiratory Medicine

Volumn 96, Issue 6, 2002, Pages 375-381

  Barta, S K ^a   Crawford, A ^b   Roberts, C Michael ^b  

^a KING GEORGE HOSPITAL   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Chronic lung disease; Copd; Domiciliary; Home; Nebuliser(s); Treatment

Indexed keywords

GLUCOCORTICOID; IPRATROPIUM BROMIDE; SALBUTAMOL; BRONCHODILATING AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CAREGIVER; CHRONIC LUNG DISEASE; CONTROLLED STUDY; COST CONTROL; DISEASE CONTROL; DYSPNEA; EXERCISE; FEMALE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH SURVEY; HEART PALPITATION; HOME CARE; HOSPITAL CARE; HUMAN; LACRIMATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MUSCLE CRAMP; NEBULIZATION; NEBULIZER; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERFORMANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SELF CONCEPT; SIDE EFFECT; SOMNOLENCE; SYMPTOM; TASTE DISORDER; THRUSH; TREATMENT OUTCOME; TREMOR; UNITED KINGDOM; VERTIGO; WELLBEING; XEROSTOMIA; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; INHALATIONAL DRUG ADMINISTRATION; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; STANDARD; STATISTICS; UTILIZATION REVIEW;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; CHRONIC DISEASE; FEMALE; HOME CARE SERVICES; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0036591408     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1292     Document Type: Article

References (23)

1. Newhouse M, Dolovich M. Aerosol therapy: nebuliser vs. metered dose inhaler. Chest 1987; 91: 799-800.
2. O'Driscoll B. Home nebuliser therapy-Is it effective? Respir Med 1991; 85: 1-3.
3. Braendli O. Maintenance and servicing of nebulisers. Eur Respir Rev 1994; 4: 102-103.
4. Dodd ME, Hanley SP, Johnson SC, Webb AK. District nebuliser compressor service: reliability and cost. Thorax 1994; 50: 82-84.
5. Hall IP, Callow IM, Evans SA, Johnston IDA. Audit of a complete home nebuliser service provided by a respiratory nurse specialist. Respir Med 1994; 88: 429-433.
6. Mansfield K. Evaluating a nebuliser service to improve patient care. Nursing Times 1996; 92: 27-29
7. Anderson L, Boethius G. Effect of domiciliary treatment with nebulized beta2-stimulants-a retrospective follow-up of 102 patients. Eur J Respir Dis 1984; 65 (Suppl. 136): 205-212.
8. Jaeschke R, Guyatt GH, Willan A, Cook D, Harper S, Morris J, Ramsdale H, Haddon R, Newhouse M. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation. Thorax 1994; 49: 479-484.
9. Muers MF. The rational use of nebulisers in clinical practice. Eur Respir Rev 1997; 7: 189-197.
10. Boe J. Domiciliary nebulized beta-agonists. Eur J Respir Dis 1984; 65 (Suppl. 136): 193-203.
11. Bosley CM, Corden ZM, Rees PJ, Cochrane GM. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996; 9: 2346-2350.
12. Morrison JFJ, Jones PC, Muers MF. Assessing physiological benefit from domiciliary nebulized bronchodilatators in severe airflow limitation. Eur Respir J 1992; 5: 424-429.
13. O'Driscoll B, Bernstein A. A long-term study of symptoms, spirometry and survival amongst home nebuliser users. Respir Med 1996; 90: 561-566.
14. Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax 2000; 55: 650-656.
15. Current best practice for nebuliser treatment. Thorax 1997; 52 (Suppl. 2).
16. Hyland ME, Singh SJ, Sodergren SC, Morgan MP. Development of a shortened version of the Breathing Problems Questionnaire suitable for use in a pulmonary rehabilitation clinic: a purpose-specific, disease-specific questionnaire. Qual Life Res 1998; 7: 227-233.
17. Boe J, et al. ERS nebuliser guidelines. Eur Respir Rev 2000; 10: 495-458.
18. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
19. Gerber RB, Kavuru M. Does salmeterol increase mortality in patients with COPD? Cleve Clin J Med 2001; 68: 600-601.
20. Walters EH, Cockroft A, Griffiths T, Rocchiccioli K, Davies BH. Optimal dose of salbutamol respiratory solution: comparison of three doses with plasma levels. Thorax 1981; 36: 625-628.
21. Roberts CM, Lowe D, Buckland CE, et al. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57: 137-141.
22. Godden DJ, Robertson A, Currie N, Legge JS, Friend JA, Douglas JG. Domiciliary nebuliser therapy-a valuable option in chronic asthma and chronic obstructive pulmonary disease? Scottish Med J 1998; 43: 48-51.
23. Fallowfield L. Participation of patients in decisions about treatment for cancer. Br Med J 2001; 323: 1144.